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Computed tomography scan based
prediction of the vulnerable carotid plaque
Hadi Mahmoud Haider Diab1, Lars Melholt Rasmussen2, Stevo Duvnjak3, Axel Diederichsen4,
Pia Søndergaard Jensen2 and Jes Sanddal Lindholt1*
Abstract
Background: Primary to validate a commercial semi-automated computed tomography angiography (CTA) –software
for vulnerable plaque detection compared to histology of carotid endarterectomy (CEA) specimens and secondary
validating calcifications scores by in vivo CTA with ex vivo non-contrast enhanced computed tomography (NCCT).
Methods: From January 2014 to October 2016 53 patients were included retrospectively, using a cross-sectional design.
All patients underwent both CTA and CEA. Sixteen patients had their CEA specimen NCCT scanned. The semi-automated
CTA software analyzed carotid stenosis using different HU values defining plaque components. The predictive values of
CTA based detection of vulnerable plaques were calculated. Quantification of calcifications on CTA using region of
interest (ROI)-function and mathematical equations was done manually, and validated by NCCT of the CEA specimen.
Results: The semi-automated CTA software had a sensitivity, specificity, positive predictive value (PPV) and negative
predictive value (NPV) of 89.1% (95% CI, 73.6% - 96.4%), 31.3% (95% CI, 12.1% - 58.5%), 75% (95% CI, 59.3% - 86.2%) and
55.6% (95% CI, 22.6% - 84.6%). Strong correlation between in vivo CTA and ex vivo NCCT in quantification of calcification
was observed, but CTA systematically underestimated calcificationsscore (CALS) with increasing calcification.
Conclusion: The CTA-software cannot be used in risk assessment of patients, due to poor specificity and NPV.
The correlation between in vivo CTA and ex vivo NCCT was strong, proposing it to be used in both scientifically and
clinical settings, but studies with larger sample sizes are needed.
Keywords: Carotid stenosis, Computed tomographic angiography, Histological components, Semi-automated CTA
software, Calcifications score
Background
Cerebral stroke is a well-known cause of mortality and
morbidity primarily affecting the lives of the elderly
population worldwide [1]. Stenosis of the carotid artery
presents one of the major sources to cerebral stroke. Du-
plex ultrasound and Computed Tomographic Angiog-
raphy (CTA) is used pre-operatively, to evaluate the
degree of carotid stenosis (CS) and combined with cere-
bral symptomology to decide whether the carotid end-
arterectomy (CEA) is beneficial or not. According to
European Carotid Surgery Trial [2] prophylactic CEA is
beneficial when the symptomatic CS is 70% or greater.
However, the risk of stroke or mortality within 30 days
of prophylactic CEA is 2.5% and 1% respectively [3]. Fur-
thermore, cerebral stroke can be caused by other dis-
eases in coexistence with CS. Due to those risks, a better
selection of patients to CEA is warranted.
CTA is a noninvasive and widely used to confirm se-
verity of CS and accessibility by CEA [4]. In addition
CTA software’s have been developed to detect vulnerable
plaques with high risk of recurrent cerebral attacks.
However, the evidence of the usefulness in these
methods are conflicting but still commercial available
softwares are offered without proven validity [5, 6].
The role of calcification in plaque stability is still uncer-
tain. A histopathological study [7] subdivided calcifica-
tions into macrocalcifications and microcalcifications and
concluded macrocalcifications functions as a plaque
stabilizer while microcalcifications instabilizing the plaque.
Conversely, investigators [8–10] using CTA found the
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volume of plaque calcifications was higher in asymptom-
atic cases. However, this has not been confirmed in symp-
tomatic cases, which in many centres are the only
indication for CEA and whether CTAs can be used for
calcification quantification is controversial. In addition,
CTA can’t detect microcalcifications which could be an
undetected risk factor for plaque instability.
Consequently, this study aimed primary to validate the
ability of a semi-automated CTA-software to discriminate
between vulnerable and stable plaques compared to the
histology of CEA specimens as a golden standard. Second-
ary, to investigate if microcalcifications and macrocalcifi-
cations contribute to plaque stability or instability. Thirdly
to examine whether plaque calcification estimated by in
vivo CTA is comparable with plaque calcification esti-
mated by ex vivo non-contrast enhanced CT (NCCT).
Methods
Patient population
From January 2014 to October 2016 61 patients were
enrolled retrospectively using a cross-sectional study
design. Inclusion criteria were: (1) patients diagnosed
with Amaurosis Fugax, Transit Ischemic Attack (TIA),
minor and/or major stroke; (2) preoperatively CTA scan;
(3) underwent CEA.
Amaurosis Fugax is defined as a transit loss of vision
on one or both eyes and lasts for a few seconds. TIA as
neurological symptoms that disappear within 24 h of on-
set, and cerebral stroke defined as neurological symp-
toms that remain after 24 h of onset. As a standardized
protocol in our institution, all patients who were admit-
ted were examined neurologically. Symptoms and risk
factors were reported. From the patients’ medical re-
cords we noted the medical history, medication use, side
of the symptomatic carotid artery and neurological
symptoms (Table 1).
Histological protocol
Immediately after CEA surgery, carotid specimens were
placed and kept in ice cold Hanks buffered salt solution
containing 10 mM HEPES (both Biological Industries,
Beit Haemek LTD, Israel).
Table 1 Baseline characteristics of included patients stratified by presence of intraplaque haemorrhage (IPH) in the removed
stenotic carotid plaque
IPH-containing (n = 37) Non IPH-containing (n = 16) P- value
Age, y, mean (SD) 70.19 (± 9,58) 70.13 (± 7.32) .816
Sex:
- Male, % (n) 67.6 (25) 31.2 (5) <.0001
- Female, % (n) 32.4 (12) 68.8 (11) <.0001
Medical History:
- Hypertension, % (n) 56.8 (21) 81.3 (13) .091
- Diabetes mellitus, % (n) 10.8 (4) 37.5 (6) .024
- Aortic valve disease, % (n) 2.7 (1) 0 (0) .511
- Aortic valve operated, % (n) 0 (0) 0 (0) 1.00
- Atrial fibrillation, % (n) 10.8 (4) 6.3 (1) .605
- Smoking, % (n) 37.8 (14) 56.3 (9) .219
- Interval (ds)a, mean (SD) 17.92 (± 9.57) 22.38 (± 20.15) .869
Medication use:
- Statins, % (n) 43.2 (16) 62.5 (10) .202
- Vitamin K antagonists, % (n) 8.1 (3) 0 (0) .245
- Antiplatelet agents, % (n) 32.4 (12) 62.5 (10) .043
- Antihypertensiva, % (n) 51.4 (19) 81.3 (13) .043
Symptomatic carotid artery
- Left, % (n) 37.8 (14) 50.0 (8) <.0001
- Right, % (n) 62.2 (23) 50.0 (8) <.0001
Neurologic symptomatology:
- TIA, % (n) 59.5 (22) 37.5 (6) <.0001
- Stroke, % (n) 27.8 (10) 50.0 (8) <.0001
- Amourasis Fugax, % (n) 13.5 (5) 12.5 (2) .571
aInterval: Days between 1. event and surgery
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One day after surgery, the intact CEAs were sliced into
2 or 5 mm thick slices using a custom-made slicing de-
vice. The slices were numbered chronologically starting
caudally. Every third slice, beginning at slice number 2,
was formalin fixed in 4% Paraformaldehyde (4% PFA) for
3-5 days and paraffin embedded. In average, 2 slices
(minimum 1 slice and maximum 5 slices per CEA speci-
men) from a CEA specimen were fixed and analyzed
histologically.
Sections 3 μm thick, were used for general histology
staining while sections 2 μm thick, were used for immu-
nohistochemically staining.
Stainings were done systematically in the following
way: (1) Masson’s trichrome; (2) Von Kossa.
This protocol was performed at Department of Clin-
ical Pathology (Odense University Hospital).
Stained sections were scanned using NPD.view 2
version 2.4 (Hamamatsu Photonics, 812 Joko-cho,
Higashi-ku, Hamamatsu city, Japan).
Acute intraplaque hemorrhage
We define acute intraplaque haemorrage (IPH) with the
presences of erythrocytes in any slice of the CEA speci-
men. Sections were stained with Masson’s trichrome for
identification of erythrocytes [11] (Fig. 2a-c). A nominal
scale, consisting of score 0 or 1 was used to indicate IPH
or not. Score 0 indicates no presences of erythrocytes
while score 1 indicates presences of erythrocytes. IPH-
containing plaques were considered vulnerable while
non IPH-containing plaques were considered stable. The
vulnerable and stable plaques were used as the golden
standard when measuring the accuracy of the semi-
automated CTA-software.
Micro- and macrocalcification
Microcalcifications are defined as small clusters, single or
spotty-like, clusters or single calcifications (Fig. 1d-f),
while macrocalcifications are defined as big sheet-like cal-
cifications (Fig. 1g-i) as described [7] but modified. Sec-
tions were stained with Von Kossa [7]. We distinguished
between micro- and macrocalcifications based on size of
the calcifications. Usually, the size of macrocalcifications
is bigger compared to the size of microcalcifications. The
severity of micro- and macrocalcifications were graded
using an ordinal scale which consists of scores from 0 to
3. The scores are based on the percentage of micro- or
macrocalcifications covering the plaque area. Score 0 rep-
resent plaques not containing micro- or macrocalcifica-
tions (0% of plaque area), score 1 represents a mild
content of micro- or macrocalcifications (1%-33% of
Fig. 1 Microscopic apperances (a-b) Plaque with IPH (Masson’s trichrome, X1.25 and X10). c Plaque without IPH (Masson’s trichrome, X1.25). d
Microcalcifications clusters (Von Kossa, X20). e Single microcalcifications (Von Kossa, X40). f Spotty-like microcalcifications (Von Kossa, X40). g-i
Macrocalcifications (Von Kossa, X10 and X5) (j-l)
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plaque area), score 2 represents a moderate content of mi-
cro- or macrocalcifications (34%-66% of plaque area), and
score 3 represents a severe content of micro- or macrocal-
cifications (67%-100%). All sections from a CEA speci-
mens were graded and the maximum score value noted.
In vivo CTA protocol
CTA was performed on several GE CT scanners includ-
ing Discovery HD-750 64 slice, Lightspeed VCT XT 64
slice and VCT 64 slice (GE Medical Systems, Little Chal-
font, Buckinghamshire, United Kingdom) and on Sie-
mens CT scanners including SOMATOM force and
SOMATOM Definition flash (Siemens Healthcare
GmbH, Munich, Germany).
Nonionic contrast (80-100 ml of Optiray 350 Covidien,
Mallinkrodt Inc., Hazelwood, MO 63042 USA) was
injected into the antecubital vein with a rate of 4 ml/s
using a power injector. The image acquisition was initi-
ated, when the track bolus reached the aortic arch, con-
trolled by Smartprep (GE Medical Systems, Little
Chalfont, Buckinghamshire, United Kingdom).
A caudocranial scanning direction was used covering
from aortic arch to approximately 2 cm under the vertex.
In vivo CTA image analysis
CT images were transferred to AW Server version 2.0
(GE Medical Systems, Little Chalfont, Buckinghamshire,
United Kingdom) to analyze the images using Autobone
Xpress Neck function.
Semi-automated software for plaque analysis
The semi-automated CTA software by GE Medical Sys-
tems works by using two functions, for plaque analysis.
First, QuickAVA-function was used which makes it
possible to choose and analyze one vessel. Secondly,
coloridentification-function was used working by setting
two endpoints analyzing the preferred area of the carotid
plaque using defined Hounsfield units (HU) (Fig. 2). The
HU values used was, lipid component 20-39HU, fibroli-
pid component 40-59HU, fibrotic component 60-79HU,
fibrocalcificed component 80-250HU and calcification
>250HU (not shown) [5, 12].
The lipid and fibrolipid components are defined as fea-
tures of vulnerable plaque. A fibrotic component is de-
fined as a feature of stable plaques, but if lipid or
fibrolipid components occur then, it becomes a feature
of vulnerable plaques.
Fibrocalcified and calcification are defined as stabiliz-
ing features. The dominated plaque component decides
whether it’s a vulnerable of stable plaque. However, if
the carotid vessel is ulcerated [13] the plaque is counted
vulnerable.
Calculation of the calcifications score (CALS)
Calculation of the calcifications score (CALS) was done
manually using a protocol as followed: Area of the calci-
fied lesion, with CT-number > 130 HU were marked
using free-hand region of interest (ROI) and measured.
The CT-number for each calcific lesion was determined
as followed: 1 if peak HU was 130-200HU; 2 if 200-
300HU; 3 if 300-400HU; 4 if >400HU. Then, CALS is
calculated for each calcific lesion by multiplying the area
of the calcific lesion with the CT-number. Calcified le-
sions with an area under 1mm2 were ignored. All CALS
were added together, and the CALS for the whole plaque
was found. The above measurements were performed
using axial slice with a thickness of 0.625 mm, and to
Fig. 2 Appearances of a vulnerable plaque using semi-automated software on CTA. a Sagittal section of carotid artery showing the severity of CS.
b Transverse section showing the reduced lumen of the vessel. The colours illustrate the distribution of various histological components of the
CS based on different HU values, which is automatically calculated by the software
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convert this to a thickness of 3 mm we finally adjusted the
CALS for the whole plaque by multiplying 0,625/3 [14].
Ex vivo NCCT protocol
After CEA, an ex vivo NCCT scanning was performed of
the carotid specimens the same day as surgery. A Sie-
mens SOMATOM Definition Flash (Siemens Healthcare
GmbH, Munich, Germany) was used, and the protocol
was as followed: Gantry rotation time 0.28 s, 0.625 mm
collimation, acquisition 128 × 0.6 mm, 120 kV tube volt-
age, 90 mAs tube current.
Ex vivo NCCT image analysis
The CT images were transferred to a workstation, and a
dedicated software program Syngo.via (Siemens Health-
care GmbH, Munich, Germany), were used to analyze
the scans. Each calcific lesion, with HU >130 was
marked and the CALS was calculated. Finally all scores
were multiplied and the total CALS for the specimen
was automatically calculated.
Statistical analysis
Sensitivity, specificity, positive predictive value (PPV)
and negative predictive value (NPV) were calculated for
the semi-automated CTA-software compared with the
histological finding of IPH or not. Mann-Whitney U test
were used when comparing histology between the two
groups with and without IPH. Spearman correlation and
Bland-Altman plot were used to validate the association
for CALS between NCCT and CTA. To test the repro-
ducibility of the histological analysis protocol and semi-
automated CTA-software, Cohen’s kappa coefficient was
used. Results were considered significant at P < .05. SPSS
software version 24 (IBM Corporation, New York, USA)
was used for statistics.
Results
Patient population
We included 53 patients but 8 patients (15%) were ex-
cluded for not fulfilling the inclusion criteria. One had
MR-angiography instead of CTA, two had no available
data, one had CEA surgery due to hypoperfusion syn-
drome instead of cerebral stroke and four had no CTA
scan due to low eGFR. Sixteen (30%) patients had their
CEA specimens NCCT scanned postoperatively.
The patient population was stratified into two
groups, an IPH-containing group consisting of 37 pa-
tients (69.81%) with a mean (SD) age of 70.19 (±9.58)
and a non IPH-containing group consisting of 16 pa-
tients (30.19%) with a mean (SD) age of 70.13
(±7.32). The baseline characteristics are summarized
in Table 1.
Accuracy of the semi-automated CTA-software
The efficiency of the semi-automated CTA-software was
compared with carotid plaques, with and without IPH as
the golden standard. We observed a sensitivity of 89.1%
(95% CI, 73.6% - 96.4%), a specificity of 31.3% (95% CI,
12.1% - 58.5%), a PPV of 75% (95% CI, 59.3% - 86.2%)
and the NPV was 55.6% (95% CI, 22.6% - 84.6%).
Comparison of histological components
Figure 3 shows the comparison of histological calcifica-
tions between IPH-containing plaques and non IPH-
containing plaques. The non IPH-containing plaques con-
taining surprisingly more microcalcifications compared to
IPH-containing plaques (mean rank = 24.11 vs. 33.69,
P = 0.034), meanwhile no significant was observed for
macrocalcifications (mean rank = 24.39 vs. 33.03, P = 0.057)
and CALS of CTA (mean rank = 25.70 vs. 30.00, P = 0.352).
Fig. 3 The severity of macrocalcifications, microcalcifications and CTA CALS was compared between the IPH containing group and the non IPH-
containing group. Significant difference was only observed for microcalcifications (P = 0.034)
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Association between CALS for CTA and NCCT
In 16 patients CTA and NCCT images of carotid plaques
were available for comparison. Figure 4a shows a strong
correlation of CALS between CTA and NCCT with a
Spearman’s Rho correlation coefficient of 0.89 (P < 0.001).
The Bland-Altman plot (Fig. 4b) indicates when the
CALSs were small, i.e. less calcified lesions, the difference
in calcification measurement between CTA and NCCT
were minor. But when the value of CALSs increases, i.e.
severe calcified lesions CTA underestimated the CALSs
thereby making the difference between the CALSs larger.
Reproducibility of the histology and semi-automated
CTA-software method
Two observers graded 15 histology sections and their re-
sults were compared. The interobserver variation for
IPH was 0.60. For macrocalcifications and microcalcifi-
cations it was 0.88 and 0.69.
The intraobserver variation of the semi-automated
CTA-software was 0.41.
Discussion
The commercial available semi-automated CTA-
software showed unacceptable predictive values regard-
ing vulnerable plaque defined as IPH containing plaques
and poor intraobserver agreement. Secondly, microcalci-
fications were associated with plaque stabilization. How-
ever, microcalcifications is not visible at any kind of
clinical CT, and macrocalcifications had no association
with plaque stability, strong correlation of CALSs be-
tween CTA and NCCT was observed.
The semi-automated CTA-software
Many semi-automated CTA-software’s have been devel-
oped for assessing histological components of the carotid
plaque as a complement to the degree of the CS, some of
these are commercialized. Such products ought to be vali-
dated before given free for clinical use, at the consequence
of a poor product is potentially invalidating inability or
death. Consequently, we validated such a commercialized
semi-automated CTA-software which showed specificity
and NPV which hasn’t been better than throwing a coin.
Furthermore, an intraobserver variation of 0.41 was ob-
served. This is at the border of being classified as poor
based of Fleiss who characterize kappas over 0.75 as excel-
lent, 0.40 to 0.75 as fair to good, below 0.40 as poor [15].
The CTA-software uses a method that may depend on the
investigators experience in analyzing and evaluating such
CTA images. If the investigator is unexperienced this
could affect the interpretation of the plaque analysis which
could explain the poor specificity, NPV and variability
achieved in this study. However, in daily clinical life, it
seems most likely that such time consuming tasks is pro-
vided by less experienced observers.
Hetterich et al. [16] reported a good sensitivity (>
80%) and excellent specificity (< 90%) for detection of
histological components. Furthermore, the interobserver
reproducibility was excellent with excellent intraclass
correlation coefficient (0.98 or higher). These results are
in disagreement with ours, due to the fact that Hetterich
et al. uses more experienced observers (5 and 10 years
of experience) which could improve the results and a
method that could be more effective in assessing CS.
Due to the influence of observer experience on the re-
sults, it shows the need of CTA-software’s that uses
more standardized methods, which are not dependent of
the investigators experience thereby making the result
more reliable.
The carotid plaque risk factors and plaque stabilizers
No significant associations between vulnerable and
stable plaques in the severity of macrocalcifications and
Fig. 4 a Graph indicating strong positive linear correlation in measuring CALS between CTA and NCCT. (b) Bland-Altman plot. X-axis shows the
mean calcification score of the two methods. Y-axis shows the difference of the calcification score measured by the two methods. The red line
indicates mean difference, black lines indicate the 95% confidence levels of the mean. Circle dots indicates mean values for CALS between CTA
and NCCT. If no association between the difference of the measurements existed, the dots should be placed on the redline, but here a clear
tendency of increased disagreement with increasing calcification is observed
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CALS were observed. Meanwhile significant differences
were found in microcalcifications. The lack of associ-
ation between macrocalcifications and our two groups is
important to notice. Our results suggest macrocalcifica-
tions isn’t either a risk factor for plaque rupture or a
protective feature. This is in contrast with the findings
by Hunt et al. [17], who found that stroke and TIA oc-
curred less frequently in patients with large sheetlike cal-
cifications which suggests macrocalcifications is a
stabilizing feature and affords a protective effect. This
disagreement could be explained by our study popula-
tion which consists of purely symptomatic patients and
that asymptomatic patients carry a larger calcification
burden in general.
Surprisingly, a significant difference was observed for
microcalcifications which were associated with stable pla-
ques, suggesting microcalcifications to be a stabilizing fea-
ture. A previous study by Virmani et al. [18] found in
coronary atherosclerotic plaques, that microcalcifications
located in the fibrotic cap increases the risk of plaque rup-
ture significantly compared to microcalcifications located
in the lipid necrotic core. In the present study, we did not
distinguish between specific areas of the plaque when
identifying microcalcifications. Instead microcalcification
was evaluated in the carotid plaque in general. The con-
cept of subdividing calcifications into microcalcifications
and macrocalcifications is relatively new. How microcalci-
fications and macrocalcifications develop, and which func-
tion they have in carotid atherosclerotic plaques still
remains uncertain and need further investigation.
CALS between CTA and NCCT
To our knowledge this is the first study comparing in vivo
CTA and ex vivo NCCT in estimation of the severity of
calcifications of carotids. CTA is generally accepted to be
unvalid to quantify coronary artery calcifications, where
the technique was developed, but the carotid arteries are
larger and not influenced by motion artefact, and this may
make a difference. We found a strong correlation between
ex vivo NCCT and in vivo CTA CALS in the carotid arter-
ies [19, 20], but when the CALSs were very high CTA
tend to underestimate the CALSs compared to the NCCT
estimates. The reason for this underestimation may be the
contrast itself. When visualizing the carotid vessel with
contrast, the contrast tends to cause blooming artifacts of
the vessel wall, and this may cause difficulties in distin-
guishing the contrast from the calcifications, thus making
it difficult to define the borders of the calcifications. This
problem may be exaggerated if the lesions are severely cal-
cified, since these very calcified lesions have HU values re-
sembling the HU values of the contrast. However, it
suggests at least it can be used with non-parametric tools,
and that transformation may be possible for parametric
use. The latter will especially be useful scientifically and
perhaps clinically, but measurements form only 16 pa-
tients were obtained. This is a major limitation. A much
larger sample size is needed to confirm the correlation
and provide and equation for transformation of quantities
between CTA and NCCT.
Strength and limitations in our study
We consecutively included symptomatic patients with
CS, based on relevant neurologic symptoms, verified CS
with CTA and undergoing CEA. However, 15% of those
undergoing CEA weren’t included, leaving a minimal
risk of selection bias – especially regarding patients with
nephropathy. In addition, our study population consists
only of symptomatic patients, making it impossible to
generalize our results to asymptomatic patients.
Regarding information bias, such bias is possible re-
garding our histological analysis. IPH was used as a
pragmatic definition of a vulnerable plaque due to its
strong association to such [11], and the larger observer
variation regarding the standard histological definition of
vulnerable plaque [21]. This may have classified some
vulnerable plaque as stable, but probably not many taken
the high proportion of vulnerable plaques by the IPH
definition into consideration. However in that case, the
bias is towards the null hypothesis, and this may have
underestimated the validity of the CT based software
but hardly caused the unacceptable values. Further to
minimize risks of information bias regarding the second-
ary endpoints we standardized our method using ordinal
scales for histological calcifications (microcalcifications
and macrocalcifications) and nominal scale for the pres-
ence of IPH or not. Furthermore, to ensure the results
of the histological components isn’t by randomness, we
tested the interobserver variations, and showed a vari-
ation from fair to excellent. Meanwhile, the results of
the CTA-software could seriously be influenced by infor-
mation bias. This was also confirmed by the relatively
poor intraobserver variation. It must be considered as a
limitation, that we didn’t test the interobserver variation
between unexperienced and experienced observers as
this could provide further insight in whether the validity
of the software would be acceptable in the hands of very
experienced observers. Finally, our study population
consists of 53 patients, which is a relatively small sample
size with limited statistical power increasing risk of type
2 errors. However, even taken this into consideration by
exploring the 95% CI for the validity parameters of the
software tool, it still suggests unacceptable predictability.
To achieve high statistical power and avoid type 2
errors, a larger sample size is needed and warranted.
Conclusion
Extreme care should be taken when using even commer-
cial available CT technology to assess carotid plaque
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carotid morphology, and calcifications on CT scans seem
not to be associated with stable plaque. However,
contrast-enhanced CT scans may be valid for calcifica-
tion quantification but needs further investigation.
Abbrevations
CALS: Calcificationsscore; CEA: Carotid endarterectomy; CS: Carotid stenosis;
CTA: Computed tomography angiography; HU: Houndsfield units;
IPH: Intraplaque haemorrage; NCCT: Non-contrast enhanced computed
tomography; NPV: Negative predictive value; PFA: Paraformaldehyde;
PPV: Predictive positive value; ROI: Region of interest; SD: Standard deviation;
TIA: Transit ischemic attack
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